Dr. Dean Elterman

Dr. Dean Elterman
Dr. Dean S. Elterman is an Associate Professor of Urology at the University of Toronto, sub-specializing in functional urology. Dr. Elterman completed his medical degree followed by residency in urologic surgery at the University of Toronto. He became a fellow of the Royal College of Physicians and Surgeons of Canada in 2011. Dr. Elterman completed a two-year fellowship in Voiding Dysfunction, Neuro-Urology, Female Urology and Pelvic Reconstruction at Memorial Sloan-Kettering Cancer Center and New York Presbyterian Hospital/Weill Cornell Medical College in New York City. He completed his Masters degree in Clinical Epidemiology and Health Services Research at Weill Cornell Graduate School of Medical Sciences. Dr. Elterman’s clinical and research interests include voiding dysfunction including novel technologies for BPH, sacral neuromodulation, male incontinence and sexual dysfunction, and men’s health. Dr. Elterman teaches BPH surgery and neuromodulation internationally including at the AUA, SIU, ICS meetings. He is the fellowship director of Functional Urology at the University Health Network/University of Toronto. Additionally, he is the Vice Chair of the Innovators committee and Chair of the Lower Urinary Tract Dysfunction sub-committee of the Societe Internationale D’Urologie (SIU).

Languages Spoken:


Medical School:

University of Toronto


University of Toronto


Memorial Sloan-Kettering Cancer Center & Weill Cornell New York Presbyterian (New York, NY)


McGill University

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only